विवरण

Viscosupplementation is the term that describes the use of intraarticular hyaluronates for the treatment of pain in osteoarthritic joints. Viscosupplementation is a highly used palliative treatment for knee OA because of ease of application and theoretical ability to relieve symptoms by restoring and replenishing hyaluronate component into the knee joint. The global viscosupplementation market in terms of revenue is set to grow by US$ 2 के दौरान अरब 2021-2027, growing at a compound annual growth rate (सीएजीआर) का 8.7% पूर्वानुमान अवधि के दौरान, डेटा और एनालिटिक्स कंपनी स्ट्रैटेजीहेलिक्स के अनुसार. Growth in the geriatric population, increasing prevalence of knee osteoarthritis, rapid expansion of healthcare facilities in developing economies are expected to boost the market growth in the coming years.

रिपोर्ट अवधि के लिए नवीनतम बाज़ार आकार डेटा प्रदान करती है 2017-2020 और पूर्वानुमान करें 2027 covering key market aspects like sales value for viscosupplementation. The global viscosupplementation market is segmented on the basis of product, आवेदन, region. उत्पाद द्वारा, it is categorized into single-injection cycle, three-injection cycle, and five-injection cycle. The three-injection cycle segment held the largest market share in 2020. By application, the viscosupplementation market is divided into knee osteoarthritis, hip osteoarthritis, shoulder osteoarthritis, और दूसरे. The knee osteoarthritis segment accounted for the largest market share in 2020. Based on region, the viscosupplementation market is divided into North America, एशिया प्रशांत, यूरोप, and Rest of the World (ROW).

The report has profiled some of the key players of the market such as Altergon Italia Srl, Anika Therapeutics Inc., Bioventus LLC, Bloomage Freda Biopharm Co. लिमिटेड, Chugai Pharmaceutical Co. लिमिटेड, Contipro a.s., Ferring Pharmaceuticals AS, Fidia Farmaceutici S.p.A., Kewpie Corporation, Lifecore Biomedical Inc., Meiji Holdings Co. लिमिटेड, Sanofi S.A., Seikagaku Corporation, Zimmer Biomet Holdings Inc..

यह रिपोर्ट इस उद्योग में सक्रिय कंपनियों और संगठनों के लिए एक अमूल्य संसाधन है. It provides a cohesive picture of the viscosupplementation market to help drive informed decision making for industry executives, नीति निर्माताओं, अकादमिक, और विश्लेषक.

रिपोर्ट का दायरा

उत्पाद: single-injection cycle, three-injection cycle, and five-injection cycle
आवेदन: knee osteoarthritis, hip osteoarthritis, shoulder osteoarthritis, और दूसरे
क्षेत्र: उत्तरी अमेरिका, एशिया प्रशांत, यूरोप, and Rest of the World (ROW)
वर्षों पर विचार किया गया: यह रिपोर्ट उस अवधि को कवर करती है 2017 को 2027

हितधारकों के लिए मुख्य लाभ

Get a comprehensive picture of the global viscosupplementation market
विकास क्षेत्रों और निवेश के रुझानों को इंगित करें
Understand what the future of the global viscosupplementation market looks like
प्रतिस्पर्धी परिदृश्य और अवसर की खिड़की की पहचान करें

विषयसूची

1. बाज़ार परिभाषा
2. अनुसंधान क्रियाविधि
3. बाजार के आंकड़े & आउटलुक
3.1 बाजार मूल्य
3.2 बाज़ार मूल्य का पूर्वानुमान
4. Viscosupplementation Market by Product
4.1 Single-Injection Cycle
4.2 Three-Injection Cycle
4.3 Five-Injection Cycle
5. Viscosupplementation Market by Application
5.1 Knee Osteoarthritis
5.2 Hip Osteoarthritis
5.3 Shoulder Osteoarthritis
5.4 अन्य
6. Viscosupplementation Market by Region
6.1 उत्तरी अमेरिका
6.2 एशिया प्रशांत
6.3 यूरोप
6.4 Rest Of The World (Row)
7. कंपनी प्रोफाइल
7.1 Altergon Italia Srl
7.2 Anika Therapeutics Inc.
7.3 Bioventus LLC
7.4 Bloomage Freda Biopharm Co., लिमिटेड.
7.5 Chugai Pharmaceutical Co. लिमिटेड.
7.6 Contipro a.s.
7.7 Ferring Pharmaceuticals AS
7.8 Fidia Farmaceutici S.p.A.
7.9 Kewpie Corporation
7.10 Lifecore Biomedical, इंक.
7.11 Meiji Holdings Co., लिमिटेड.
7.12 Sanofi S.A.
7.13 Seikagaku Corporation
7.14 Zimmer Biomet Holdings, इंक.
8. अनुबंध
8.1 स्ट्रेटेजीहेलिक्स के बारे में
8.2 अस्वीकरण